Loading clinical trials...
Loading clinical trials...
Patients who suffer Alcohol Use Disorder (AUD) have a 30-80% incidence of thiamine deficiency causing Wernicke's Encephalopathy (WE). Intravenous (IV) thiamine replacement is standard practice in the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Glasgow Royal Infirmary
NCT04793685 · Alcohol Withdrawal
NCT06559995 · Alcohol Use Disorder, Alcohol Withdrawal, and more
NCT06644534 · MELAS Syndrome, Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
NCT06173973 · Alcohol Use Disorder, Alcohol Withdrawal, and more
NCT06840652 · Alcoholic Cirrhosis, Alcohol Abstinence, and more
Glasgow Royal Infirmary
Glasgow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions